A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated
Clinical trial NCT06429137 · COMPLETED
Trial details
- NCT number
- NCT06429137
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2025-05-19
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.